The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical outcomes in phase I trials across solid tumors and hematological malignancies.
 
Laila Belcaid
No Relationships to Disclose
 
Karen Klingenberg
No Relationships to Disclose
 
Iben Spanggaard
Honoraria - AstraZeneca
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bayer (Inst); Bioinvent (Inst); BioNTech SE (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); CDR-Life (Inst); Dragonfly Therapeutics (Inst); Genentech (Inst); Genmab (Inst); Incyte (Inst); Loxo/Bayer (Inst); Loxo/Lilly (Inst); MonTa Biosciences (Inst); MSD (Inst); Novartis (Inst); Orion (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Repare Therapeutics (Inst); Roche (Inst); Symphogen (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Incyte
 
Laurine Harsløf
No Relationships to Disclose
 
Martin Hoejgaard
Stock and Other Ownership Interests - Bavarian Nordic
Travel, Accommodations, Expenses - Repare Therapeutics
(OPTIONAL) Uncompensated Relationships - Amgen (Inst); Eikon Therapeutics (Inst); Incyte (Inst); Kinnate Biopharma (Inst); Repare Therapeutics; SERVIER (Inst)
 
Caroline Riley
No Relationships to Disclose
 
Martin Hutchings
Consulting or Advisory Role - Abbvie; AstraZeneca; Genmab; Johnson & Johnson/Janssen; Roche; Takeda
Research Funding - Abbvie (Inst); Arvinas (Inst); AstraZeneca (Inst); Celgene (Inst); Genmab (Inst); Johnson & Johnson/Janssen (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Takeda (Inst)
 
Kristoffer Rohrberg
Honoraria - MSD; MSD
Consulting or Advisory Role - Abbvie; Genmab
Research Funding - Alligator Bioscience (Inst); AstraZeneca (Inst); Bayer (Inst); Bioinvent (Inst); BioNTech SE (Inst); Bristol-Myers Squibb (Inst); Genmab (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Lilly (Inst); Loxo (Inst); Merus (Inst); MonTa Biosciences (Inst); MSD (Inst); Navire (Inst); Novartis (Inst); Orion Clinical (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Repare Therapeutics (Inst); Roche/Genentech (Inst); Symphogen (Inst); Turning Point Therapeutics (Inst)
Travel, Accommodations, Expenses - AstraZeneca (Inst)
 
Ulrik Lassen
Honoraria - Bayer; Novartis; Pfizer
Consulting or Advisory Role - Bayer; Pfizer
Research Funding - BMS (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Lilly (Inst); Pfizer (Inst); Roche (Inst)